MSD

Pembrolizumab

Biodrugs/ Drugs
Cancer
Trastuzumab + Chemotherapy with/without Pembrolizumab as First-line Treatment in Participants With HER2 Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
3Phase III in Spain, 2Phase II, 1Phase I